| 000 | 01678 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513105646.0 | ||
| 264 | 0 | _c19970402 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a1120-009X | ||
| 024 | 7 |
_a10.1179/joc.1996.8.5.387 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpanik, S | |
| 245 | 0 | 0 |
_aBacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome. _h[electronic resource] |
| 260 |
_bJournal of chemotherapy (Florence, Italy) _cOct 1996 |
||
| 300 |
_a387-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBacteremia _xepidemiology |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 |
_aFungemia _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aOfloxacin _xtherapeutic use |
| 650 | 0 | 4 |
_aOpportunistic Infections _xepidemiology |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSlovakia _xepidemiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTrupl, J | |
| 700 | 1 | _aIlavska, I | |
| 700 | 1 | _aHelpianska, L | |
| 700 | 1 | _aDrgona, L | |
| 700 | 1 | _aDemitrovicova, A | |
| 700 | 1 | _aKukuckova, E | |
| 700 | 1 | _aStudena, M | |
| 700 | 1 | _aPichna, P | |
| 700 | 1 | _aOravcova, E | |
| 700 | 1 | _aRusnakova, V | |
| 700 | 1 | _aKoren, P | |
| 700 | 1 | _aLacka, J | |
| 700 | 1 | _aKrcmery, V | |
| 773 | 0 |
_tJournal of chemotherapy (Florence, Italy) _gvol. 8 _gno. 5 _gp. 387-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1179/joc.1996.8.5.387 _zAvailable from publisher's website |
| 999 |
_c8949668 _d8949668 |
||